Drug details
Xtandi (enzalutamide capsules)
type of Antineoplastics, Antiandrogen, Antiandrogens
Xtandi (enzalutamide) is an androgen receptor inhibitor indicated for the treatment of prostate cancer in patients who have previously received Docefrez (docetaxel).
The drug is often used to treat Prostate cancer .
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- fever,
- shortness of breath,
- confusion,
- chest pain,
- vision problems,
- seizure,
- severe headache,
- blurred vision,
- pounding in your neck or ears,
- weakness,
- nosebleed,
- loss of consciousness,
- anxiety,
- wheezing
- buzzing in your ears,
- red or pink urine,
- thinking problems,
- cough with yellow or green mucus,
- stabbing chest pain, and
The following drugs are related to Xtandi, either as a replacement or used together:
- Axumin (fluciclovine f 18 intravenous injection)
- Casodex (bicalutamide)
- Camcevi (leuprolide mesylate injectable emulsion)
- Nubeqa (darolutamide tablets)
- Docefrez (docetaxel)
- Taxotere (docetaxel for injection)
- Eligard (leuprolide acetate)
- Eulexin (flutamide)
- Posluma (flotufolastat f 18 injection)
- Locametz (kit for the preparation of gallium ga 68 aozetotide injection)
- Lupron Depot 11.25 mg (leuprolide acetate for depot suspension)
- Lupron Depot 7.5 mg (leuprolide acetate for depot suspension)
- Lupron Depot (leuprolide acetate for depot suspension)
- Lutrate Depot (leuprolide acetate for depot suspension)
- Lupron Depot 22.5 (leuprolide acetate for depot suspension injection)
- Viadur (leuprolide acetate implant)
- Lupron (leuprolide acetate injection)
- Lupron Depot 3.75 mg (leuprolide acetate injection)
- Pluvicto (lutetium lu 177 vipivotide tetraxetan)
- Nilandron (nilutamide tablets)
- Trelstar Depot (triptorelin pamoate for injectable suspension)
- Trelstar LA (triptorelin pamoate for injectable suspension)